Author:
Igari Fumie,Tanaka Hisashi,Giuliano Armando E.
Reference178 articles.
1. Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, Chung G, Clement J, Gao J, Hunkapiller N et al: Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Annals of Oncology.
2. Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 study;Abida;Clin. Cancer Res.,2020
3. Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration;Abida;J. Clin. Oncol.,2020
4. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors;Adalsteinsson;Nat. Commun.,2017
5. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial;Albain;Lancet Oncol.,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献